Fexofenadine hydrochloride, , >98% (HPLC)

Code: f9427-10mg D2-231

Not available outside of the UK & Ireland.

Application

Fexofenadine hydrochloride has been used as a non-cationic ampliphilic antihistamines in NCI-H661 cells and as a histamine H1 receptor antagonist in mice


read more

Your Price
£191.00 10MG

Not available outside of the UK & Ireland.

Application

Fexofenadine hydrochloride has been used as a non-cationic ampliphilic antihistamines in NCI-H661 cells and as a histamine H1 receptor antagonist in mice

Biochem/physiol Actions

Fexofenadine is used in treating allergic rhinitis and chronic idiopathic urticaria. It may give relief in bothersome symptom and is a second-generation antihistamines. Fexofenadine provides better relief compared to other antihistamines for nasal congestion. It is the active metabolite of terfenadine and bring down allergen-induced symptoms.

Fexofenadine is a non-sedating H1 histamine receptor antagonist.

Features and Benefits

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

10, 50 mg in glass bottle

assay>98% (HPLC)
colorwhite to beige
formpowder
Gene Informationhuman ... HRH1(3269)
InChI keyRRJFVPUCXDGFJB-UHFFFAOYSA-N
InChI1S/C32H39NO4.ClH/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27;/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36);1H
originatorSanofi Aventis
Quality Level100
SMILES stringCl[H].CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4
solubilityDMSO: soluble ≥5 mg/mL
storage temp.−20°C
Code
Description
Unit Size
List Price
Qty
F9427-50MG
Unit:50MG
List Price: £643.00
Source:List Price
ADD
Cas Number153439-40-8
This product has met the following criteria: